Avantor, Inc. Provides Earnings Guidance for the First Quarter for the First Quarter and Full Year 2024
February 14, 2024 at 08:00 am EST
Share
Avantor, Inc. provided earnings guidance for the first quarter for the first quarter and full year 2024. For the quarter, the company expects organic revenue to decline approximately 6.5% to 5.5%, and reported revenue to decline approximately 6% to 5%.
For the year, the company expects organic revenue growth of negative 2% to plus 1%. Based on current FX rates, The company expects a modest tailwind from FX of approximately 0.3%, leading to reported revenue growth of negative 1.7% to positive 1.3%.
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
AVANTOR, INC. 
